Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hawkins Capital Selling Off Its Top Tech Stocks

Page 1 of 2

Hawkins Capital, headed by Russell Hawkins, recently filed its 13F form with the Securities and Exchange Commission for the reporting period of June 30. Hawkins set up his own fund back in 2003, after previously holding down a position managing Dreyfus’ mutual funds, where he oversaw some $8 billion in assets. These days, his investment firm controls around $1 billion in assets and mostly employs a long/short approach to investing. The total market value of Hawkins’ portfolio as of the reporting date was $285.25 million, a decrease of 33% from the end of March. Among the positions that contributed to the decline in the fund’s portfolio value were many of its top tech picks, including Intel Corporation (NASDAQ:INTC), Cisco Systems Inc (NASDAQ:CSCO) and EMC Corporation (NYSE:EMC), all of which were slashed during the second quarter. In this article we are going to take a closer look at how these companies performed over the past few months and consider how other money managers are trading them.

Intel Corporation (NASDAQ:INTC), microprocessor, Sign, Logo, chip, hardware, processor

NorGal /

Professional investors like Hawkins spend considerable time and money conducting due diligence on each company they invest in, which makes them the perfect investors to emulate. However, we also know that the returns of hedge funds on the whole have not been good for several years, underperforming the market. We analyzed the historical stock picks of these investors and our research revealed that the small-cap picks of these funds performed far better than their large-cap picks, which is where most of their money is invested and why their performances as a whole have been poor. Why pay fees to invest in both the best and worst ideas of a particular hedge fund when you can simply mimic the best ideas of the best fund managers on your own? A portfolio consisting of the 15 most popular small-cap stock picks among the funds we track has returned more than 123% and beaten the market by more than 65 percentage points since the end of August 2012 (see the details).

Russell Hawkins
Russell Hawkins
Hawkins Capital

Following up a 52% cut to its position in Intel Corporation (NASDAQ:INTC), Hawkins Capital ended the second quarter with some 1.07 million shares valued at $32.42 million. For many people this $139.04 billion computer equipment manufacturer from Santa Clara, California, will need little introduction, as some of you undoubtedly have Intel computers at home, while others hold the company’s shares. While the former may be pleased with their Intel investment, we can say the latter are definitely disappointed this year, as Intel Corporation (NASDAQ:INTC) has lost around 20.45% of its value during 2015. In the middle of July the company reported EPS of $0.55 and revenues of $13.2 billion for its second quarter financial results, while the expectations stood at $0.50 and $13.04 billion respectively. While the results look strong, there are warning signs hiding behind the numbers, as most market expects are afraid that the company will not manage to adjust to the slowing PC demand over the long term. Among the other funds that we follow, Jean-Marie Eveillard‘s First Eagle Investment Management holds 28.48 million shares as of June 30. First Eagle trimmed its position by 1% during the second quarter.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!